Anthracene-9, 10-dione dioxime compound prodrugs and their uses

US9725473B2 · kind B2 · utility

Assignee

• Beta Cat Pharmaceuticals, Inc. · US

Inventors

• Hariprasad Vankayalapati · Draper, US
• Xiaohui Liu · Fujian, CN
• Sunil Sharma · Salt Lake City, US
• Srinivas Rao Kasibhatla · San Diego, US
• Seelam Venkata Reddy · Ghanpur, IN

Key dates

• Filing date: Jul 28, 2016
• Grant date: Aug 8, 2017
• Expiry date: Jul 28, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F9/59
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures; including, salts thereof that act as anti-cancer and anti-tumor agents, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents.